Literature DB >> 31379021

Clinical staging of upper urinary tract urothelial carcinoma for T staging: Review and pictorial essay.

Yukiko Honda1, Yuko Nakamura1, Jun Teishima2, Keisuke Goto2, Toru Higaki1, Keigo Narita1, Motonori Akagi1, Hiroaki Terada1, Yoko Kaichi1, Shinsuke Fujii2, Tetsutaro Hayashi2, Akio Matsubara2, Kazuhiro Sentani3, Wataru Yasui3, Makoto Iida1, Kazuo Awai1.   

Abstract

Upper urinary tract urothelial carcinoma is staged using the TNM classification of malignant tumors. Preoperative TNM is important for treatment planning. Computed tomography urography is now widely used for clinical survey of upper urinary tract carcinoma because of its diagnostic accuracy. Computed tomography urography is recommended as the first-line imaging procedure in several guidelines. Several reports stated that computed tomography urography is also useful for staging. However, no educational and practical reviews detailing the T staging of upper urinary tract urothelial carcinomas using imaging are available. We discuss the scanning protocol, T staging using computed tomography urography, limitations, magnetic resonance imaging, computed tomography comparison and pitfalls in imaging of upper urinary tract urothelial carcinoma. A recent study reported the high diagnostic accuracy of computed tomography urography with respect to T3 or higher stage tumors. To date, images that show a Tis-T2 stage have not been reported, but various studies are ongoing. Although magnetic resonance imaging has lower spatial resolution than computed tomography urography, magnetic resonance imaging can be carried out without radiation exposure or contrast agents. Magnetic resonance imaging also offers the unique ability of diffusion-weighted imaging without contrast agent use. Some researchers reported that diffusion-weighted imaging is useful not only for detecting lesions, but for predicting the T stage and tumor grade. We recommend the appropriate use of computed tomography and magnetic resonance while considering the limitations of each modality and the pitfalls in upper urinary tract urothelial carcinoma imaging.
© 2019 The Japanese Urological Association.

Entities:  

Keywords:  clinical staging; computed tomography urography; magnetic resonance imaging; upper urinary tract; urothelial carcinoma

Year:  2019        PMID: 31379021     DOI: 10.1111/iju.14068

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  8 in total

1.  Liquid Biopsy Landscape in Patients with Primary Upper Tract Urothelial Carcinoma.

Authors:  Stephanie N Shishido; Alireza Ghoreifi; Salmaan Sayeed; George Courcoubetis; Amy Huang; Brandon Ye; Sankalp Mrutyunjaya; Inderbir S Gill; Peter Kuhn; Jeremy Mason; Hooman Djaladat
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

2.  Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum-based chemotherapy.

Authors:  Daiki Taniyama; Naoya Sakamoto; Tsuyoshi Takashima; Masahiko Takeda; Quoc Thang Pham; Shoichi Ukai; Ryota Maruyama; Kenji Harada; Takashi Babasaki; Yohei Sekino; Tetsutaro Hayashi; Kazuhiro Sentani; Yves Pommier; Junko Murai; Wataru Yasui
Journal:  Cancer Sci       Date:  2021-12-07       Impact factor: 6.716

Review 3.  MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer?

Authors:  Alessandra Cinque; Anna Capasso; Riccardo Vago; Matteo Floris; Michael W Lee; Roberto Minnei; Francesco Trevisani
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

Review 4.  Imaging Tips and Tricks in Management of Renal and Urothelial Malignancies.

Authors:  Shanti Ranjan Sanyal; Ankur Arora; Amin Nisreen; Khattab Mohamed; Saeed Kilani Mohammad; Deb Baruah
Journal:  Indian J Radiol Imaging       Date:  2022-07-05

5.  High Carbohydrate Antigen 19-9 Levels Indicate Poor Prognosis of Upper Tract Urothelial Carcinoma.

Authors:  Seung-Hwan Jeong; Jang Hee Han; Chang Wook Jeong; Hyeon Hoe Kim; Cheol Kwak; Hyeong Dong Yuk; Ja Hyeon Ku
Journal:  Front Oncol       Date:  2022-07-14       Impact factor: 5.738

Review 6.  Neoadjuvant Chemotherapy before Nephroureterectomy in High-Risk Upper Tract Urothelial Cancer: A Systematic Review and Meta-Analysis.

Authors:  David Oswald; Maximilian Pallauf; Susanne Deininger; Peter Törzsök; Manuela Sieberer; Christian Eiben
Journal:  Cancers (Basel)       Date:  2022-10-04       Impact factor: 6.575

7.  Tumor heterogeneity evaluated by computed tomography detects muscle-invasive upper tract urothelial carcinoma that is associated with inflammatory tumor microenvironment.

Authors:  Keisuke Goto; Yukiko Honda; Kenichiro Ikeda; Kenshiro Takemoto; Toru Higaki; Tetsutaro Hayashi; Kohei Kobatake; Yuko Nakamura; Yohei Sekino; Shogo Inoue; Kazuo Awai; Wataru Yasui; Jun Teishima
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

Review 8.  Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic.

Authors:  Christopher J D Wallis; Giacomo Novara; Laura Marandino; Axel Bex; Ashish M Kamat; R Jeffrey Karnes; Todd M Morgan; Nicolas Mottet; Silke Gillessen; Alberto Bossi; Morgan Roupret; Thomas Powles; Andrea Necchi; James W F Catto; Zachary Klaassen
Journal:  Eur Urol       Date:  2020-05-03       Impact factor: 20.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.